• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管平滑肌细胞中的内源性组织因子途径抑制剂抑制动脉血栓形成。

Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.

机构信息

Institute of Biomedical Sciences, Fudan University, Shanghai, 200032, China.

Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.

出版信息

Front Med. 2017 Sep;11(3):403-409. doi: 10.1007/s11684-017-0522-y. Epub 2017 May 27.

DOI:10.1007/s11684-017-0522-y
PMID:28550640
Abstract

Tissue factor pathway inhibitor (TFPI) is the main inhibitor of tissue factor-mediated coagulation. TFPI is expressed by endothelial and smooth muscle cells in the vasculature. Endothelium-derived TFPI has been reported to play a regulatory role in arterial thrombosis. However, the role of endogenous TFPI in vascular smooth muscle cells (VSMCs) in thrombosis and vascular disease development has yet to be elucidated. In this TFPI mice crossbred with Sma-Cre mice were utilized to establish TFPI conditional knockout mice and to examine the effects of VSMC-directed TFPI deletion on development, hemostasis, and thrombosis. The mice with deleted TFPI in VSMCs (TFPI) reproduced viable offspring. Plasma TFPI concentration was reduced 7.2% in the TFPI mice compared with TFPI littermate controls. Plasma TFPI concentration was also detected in the TFPI (mice deleted TFPI in endothelial cells and cells of hematopoietic origin) mice. Plasma TFPI concentration of the TFPI mice was 80.4% lower (P < 0.001) than that of the TFPI mice. No difference in hemostatic measures (PT, APTT, and tail bleeding) was observed between TFPI and TFPI mice. However, TFPI mice had increased ferric chloride-induced arterial thrombosis compared with TFPI littermate controls. Taken together, these data indicated that endogenous TFPI from VSMCs inhibited ferric chloride-induced arterial thrombosis without causing hemostatic effects.

摘要

组织因子途径抑制剂(TFPI)是组织因子介导的凝血的主要抑制剂。TFPI 由血管中的内皮细胞和平滑肌细胞表达。已报道内皮细胞衍生的 TFPI 在动脉血栓形成中发挥调节作用。然而,内源性 TFPI 在血管平滑肌细胞(VSMCs)中在血栓形成和血管疾病发展中的作用尚未阐明。在这项研究中,将 TFPI 基因敲除小鼠与 Sma-Cre 小鼠杂交,建立 TFPI 条件性敲除小鼠,并研究 VSMC 定向 TFPI 缺失对发育、止血和血栓形成的影响。在 VSMCs 中缺失 TFPI 的小鼠(TFPI)能够繁殖存活的后代。与 TFPI 同窝仔鼠相比,TFPI 小鼠的血浆 TFPI 浓度降低了 7.2%。在 TFPI 小鼠(内皮细胞和造血细胞来源的细胞中缺失 TFPI 的小鼠)中也检测到了血浆 TFPI 浓度。TFPI 小鼠的血浆 TFPI 浓度比 TFPI 小鼠低 80.4%(P<0.001)。TFPI 和 TFPI 小鼠之间的止血措施(PT、APTT 和尾部出血)没有差异。然而,与 TFPI 同窝仔鼠相比,TFPI 小鼠的氯化铁诱导的动脉血栓形成增加。总之,这些数据表明来自 VSMCs 的内源性 TFPI 抑制了氯化铁诱导的动脉血栓形成,而不会引起止血作用。

相似文献

1
Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.血管平滑肌细胞中的内源性组织因子途径抑制剂抑制动脉血栓形成。
Front Med. 2017 Sep;11(3):403-409. doi: 10.1007/s11684-017-0522-y. Epub 2017 May 27.
2
Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis.内皮细胞衍生组织因子途径抑制剂调节动脉血栓形成,但对于发育或止血并非必需。
Blood. 2010 Sep 9;116(10):1787-94. doi: 10.1182/blood-2009-10-250910. Epub 2010 Jun 1.
3
The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.组织因子途径抑制剂在血管平滑肌细胞靶向表达对小鼠动脉血栓形成模型的影响。
Thromb Haemost. 2004 Sep;92(3):495-502. doi: 10.1160/TH04-01-0006.
4
Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT/YAP pathway.小鼠血管平滑肌细胞中TFPI-1的条件性敲除通过增强AMOT/YAP信号通路加速动脉粥样硬化。
Int J Cardiol. 2017 Feb 1;228:605-614. doi: 10.1016/j.ijcard.2016.11.195. Epub 2016 Nov 12.
5
Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury.血管平滑肌衍生的组织因子对氯化铁诱导损伤后的动脉血栓形成至关重要。
Blood. 2009 Jan 15;113(3):705-13. doi: 10.1182/blood-2007-05-090944. Epub 2008 Oct 17.
6
Adenovirus-mediated tissue factor pathway inhibitor gene transfer induces apoptosis by blocking the phosphorylation of JAK-2/STAT-3 pathway in vascular smooth muscle cells.腺病毒介导的组织因子途径抑制剂基因转导通过阻断血管平滑肌细胞中 JAK-2/STAT-3 通路的磷酸化诱导细胞凋亡。
Cell Signal. 2012 Oct;24(10):1909-17. doi: 10.1016/j.cellsig.2012.06.001. Epub 2012 Jun 15.
7
[Effect of adenovirus-mediated tissue factor pathway inhibitor gene transfer on apoptosis of rat vascular smooth muscle cells].腺病毒介导的组织因子途径抑制物基因转移对大鼠血管平滑肌细胞凋亡的影响
Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Jun;37(6):542-7.
8
KLF11 (Krüppel-Like Factor 11) Inhibits Arterial Thrombosis via Suppression of Tissue Factor in the Vascular Wall.KLF11(Krüppel 样因子 11)通过抑制血管壁中的组织因子抑制动脉血栓形成。
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):402-412. doi: 10.1161/ATVBAHA.118.311612.
9
Deletion of tissue factor pathway inhibitor isoform beta or gamma, but not alpha, improves clotting in hemophilic mice.组织因子途径抑制物异构体β或γ缺失,而非α缺失,可改善血友病小鼠的凝血功能。
J Thromb Haemost. 2024 Oct;22(10):2681-2691. doi: 10.1016/j.jtha.2024.06.006. Epub 2024 Jun 24.
10
Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors.组织因子途径抑制剂在血管平滑肌细胞中的表达及其受生长因子的调控
Circ Res. 1998;83(12):1264-70. doi: 10.1161/01.res.83.12.1264.

引用本文的文献

1
Exploration on the effect of anserine on the alleviation of DVT and its molecular mechanism.鹅肌肽对减轻深静脉血栓形成的作用及其分子机制的探讨。
Front Pharmacol. 2024 May 23;15:1402758. doi: 10.3389/fphar.2024.1402758. eCollection 2024.
2
Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy.仿生血小板伪装载药聚吡咯用于精确靶向抗血栓治疗。
J Nanobiotechnology. 2023 Nov 22;21(1):439. doi: 10.1186/s12951-023-02197-3.
3
Calcium in Vascular Smooth Muscle Cell Elasticity and Adhesion: Novel Insights Into the Mechanism of Action.

本文引用的文献

1
Inhibition of Polyamine Uptake Potentiates the Anti-Proliferative Effect of Polyamine Synthesis Inhibition and Preserves the Contractile Phenotype of Vascular Smooth Muscle Cells.抑制多胺摄取可增强多胺合成抑制的抗增殖作用,并维持血管平滑肌细胞的收缩表型。
J Cell Physiol. 2016 Jun;231(6):1334-42. doi: 10.1002/jcp.25236. Epub 2015 Nov 20.
2
New insights into the biology of tissue factor pathway inhibitor.组织因子途径抑制剂生物学的新见解。
J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S200-7. doi: 10.1111/jth.12897.
3
Endothelial cell-anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice.
血管平滑肌细胞弹性和黏附中的钙:作用机制的新见解
Front Physiol. 2019 Aug 7;10:852. doi: 10.3389/fphys.2019.00852. eCollection 2019.
4
KLF11 (Krüppel-Like Factor 11) Inhibits Arterial Thrombosis via Suppression of Tissue Factor in the Vascular Wall.KLF11(Krüppel 样因子 11)通过抑制血管壁中的组织因子抑制动脉血栓形成。
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):402-412. doi: 10.1161/ATVBAHA.118.311612.
内皮细胞锚定的组织因子途径抑制剂调节小鼠肿瘤向肺的转移。
Mol Carcinog. 2016 May;55(5):882-96. doi: 10.1002/mc.22329. Epub 2015 May 6.
4
Direct interaction of kindlin-3 with integrin αIIbβ3 in platelets is required for supporting arterial thrombosis in mice.在小鼠中,血小板中的踝蛋白-3与整合素αIIbβ3的直接相互作用是支持动脉血栓形成所必需的。
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1961-7. doi: 10.1161/ATVBAHA.114.303851. Epub 2014 Jun 26.
5
Biology of tissue factor pathway inhibitor.组织因子途径抑制物的生物学特性。
Blood. 2014 May 8;123(19):2934-43. doi: 10.1182/blood-2013-11-512764. Epub 2014 Mar 11.
6
Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.组织因子途径抑制物-α在凝血起始时抑制凝血酶原酶。
Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17838-43. doi: 10.1073/pnas.1310444110. Epub 2013 Oct 14.
7
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.组织因子途径抑制物在动脉粥样硬化和动脉血栓形成中的作用。
Blood Rev. 2013 May;27(3):119-32. doi: 10.1016/j.blre.2013.03.001. Epub 2013 Apr 28.
8
Altered contractile phenotypes of intestinal smooth muscle in mice deficient in myosin phosphatase target subunit 1.肌球蛋白磷酸酶靶蛋白 1 缺失小鼠的肠道平滑肌收缩表型改变。
Gastroenterology. 2013 Jun;144(7):1456-65, 1465.e1-5. doi: 10.1053/j.gastro.2013.02.045. Epub 2013 Mar 13.
9
Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ.比较人组织因子途径抑制物(TFPI)α和 TFPIβ的抑制活性。
J Thromb Haemost. 2013 May;11(5):911-8. doi: 10.1111/jth.12188.
10
Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S.鉴定 TFPI Kunitz 结构域 3 中对蛋白 S 增强其活性起重要作用的功能残基。
Blood. 2012 Dec 13;120(25):5059-62. doi: 10.1182/blood-2012-05-432005. Epub 2012 Oct 16.